AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
PUK
ACCE-researched

Prudential Public Limited Company Common Stock (PUK) fair value

Financial Services · Insurance - Life · NYSE · United States
$23.70-1.29%
Market cap $29.1BNext earnings 2026-08-27Updated Oct 18, 2026
Our verdict
Trades 11% below our fair value
Price
$23.70
Model fair valueConfidence: good
$26.53
Model range
$18.52 to $33.39
Fair value $26.53
Price $23.70
2 models fit Prudential Public Limited Company Common Stock and they disagree: 0 of 2 land within 15% of the average.
Two or more of our models back this value.
Near fair value(i)
Valued as an insurer: Residual income, P/E comparison, and Dividend discount.
ACCE opinionPrudential Public Limited Company Common Stock (PUK)
Fair value (2 models)
$26.53
ACCE price target
$27.40
Rating
Fairly valued
Horizon
12 months
Fair value published on 10 Oct 2026, 00:00 CEST; previously $29.30 since 4 Oct 2026, 00:00 CEST.
ACCE price target published on 18 Oct 2026, 01:52 CEST; previously $31.00 since 21 Sept 2026, 00:00 CEST.
Rating published on 18 Oct 2026, 16:04 CEST.
Price used: $23.70 at the close on 23 Oct 2026, 22:00 CEST.
Models: Dividend discount, P/E comparison, and Residual income.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
10.7% below
+11.9% to fair value
ACCE score
49
out of 100
Analysts
100% buy
4 covering
P/E
8.3x
forward 14.7x
1-year return
-13.3%
Dividend yield
2.31%

Prudential Public Limited Company Common Stock in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Prudential plc, the London-listed holding company behind Prudential Financial's Asian and African life insurance franchises, earns most of its profit from regular-premium and single-premium life policies sold through bancassurance partners and agency forces across Hong Kong, Singapore, Indonesia and Malaysia. The structural case rests on long-duration savings and protection demand in Asian markets with low insurance penetration, where a growing middle class is buying protection products for the first time. Revenue fell 1.8% in the latest period, so the near-term catalyst is whether new business growth and margins hold up, with the market still pricing the shares at a trailing P/E of 8.4 against a forward P/E of 14.8, which implies earnings are expected to decline. At a 29.3B USD market cap, 18.7% ROE and a 28.1% operating margin, the business is profitable, but the forward multiple and negative top-line trend mean the thesis needs a deeper look at Hong Kong exposure, sales momentum, and capital generation before the name merits further work.

AI-assisted·How I use AIWritten Oct 13, 2026
⚠ Investor warnings · 3 flagsAI-assisted·How I use AI
  • high
    Earnings collapse and score deterioration
    Earnings down 23% YoY; ACCE score fell 22 points in 90 days (72 to 50). Moat score of 25 signals weakening competitive position.
  • high
    Severe long-term revenue decline
    5-year revenue CAGR of -22.2% indicates structural headwinds. Recent QoQ bounce (+18%) insufficient to offset trajectory.
  • moderate
    Heavy insider selling with no buying
    Last 10 disclosures show $121.5M in sales and zero buys. Insiders are exiting; no confidence signal.

AI research notes

AI-assisted·How I use AIWritten Oct 11, 2026 · figures from 2026-10-09 · prices to Oct 23, 2026
Why it could do well
  • Prudential trades at 8.4x trailing P/E with 18.7% ROE, suggesting the market undervalues a capital-efficient business generating strong returns.
  • The company generated $4.1B in free cash flow last year and yields 14.1%, providing substantial cash returns to shareholders at current valuation.
Why it could disappoint
  • Revenue has fallen 22.2% annually over five years, indicating a structural decline that buybacks and capital returns cannot reverse.
  • Forward P/E of 14.9x exceeds the sector median of 11.7x despite negative revenue momentum, suggesting the market has priced in recovery.
  • Consensus fair value of $26.32 offers only 10.1% upside, and just 2 of 3 valuation models support this price, indicating limited margin of safety.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where PUK's valuation models land
Price
$23.70
Model fair value
$26.53
Model range
$18.52 to $33.39
Fair value $26.53
Price $23.70
The price sits inside the model range.
Model
Fair value
Upside
Dividend discount
P/E comparison
Residual income
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Bullish100% buy · 4 covering analysts
● Strong buy 3● Buy 1● Hold 0● Sell 0● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
-1.8%
1 month
-6.2%
3 months
-19.2%
6 months
-22.9%
YTD
-23.8%
1 year
-13.3%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
18 Oct 2026, 16:04 CESTRatingFairly valuedfirst publication$24.13
18 Oct 2026, 01:52 CESTACCE price target$27.40$31.00$24.13
10 Oct 2026, 00:00 CESTFair value$26.32$29.30$23.88
4 Oct 2026, 00:00 CESTFair value$29.30$30.29$24.57
30 Sept 2026, 00:00 CESTFair value$30.29$30.70$25.20
25 Sept 2026, 00:00 CESTFair value$30.70$31.41$25.26
23 Sept 2026, 00:00 CESTFair value$31.41$30.97$26.25
21 Sept 2026, 00:00 CESTACCE price target$31.00first publication$26.09
20 Sept 2026, 00:00 CESTFair value$30.97$32.36$26.09
16 Sept 2026, 00:00 CESTFair value$32.36$32.90$26.64

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full PUK page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth7Value75Quality87Momentum25Total49
Valuation
Trailing P/E
8.3x
Forward P/E
14.7x
PEG
no data
P/B
1.61x
EV / Revenue
1.0x
Book value/sh
$3.94
Enterprise value
$31.2B
Profitability
ROE
18.7%
FCF yield
7.25%
ROIC
12.5%
Health and risk
Debt / equity
0.30
Dividend yield
2.31%
Beta
0.91

Price

-14.3% · 1Y

Ask anything about PUK

Answered from Prudential Public Limited Company Common Stock fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 50% of peers
low 4.1x8.3xhigh 23.3x
ROEbetter than 100% of peers
low 10%19%high 19%
Div yieldbetter than 0% of peers
low 2.3%2.3%high 7.1%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
PUK Prudential Public Limited Company Common Stock$23.70$2711% below8.3x18.7%8749
PRU.L Prudential£8.86£94% below8.3x18.7%8749
2601.HK China Pacific Insurance (Group) Co., Ltd.HK$25.38HK$4847% below4.1x17.5%6652
LICI.NS Life Insurance Corporation of India₹387.50₹3695% above8.0x-5565
PRU Prudential Financial Inc. Common Stock$118.17$13311% below10.7x12.0%6076
8750.T Daiichi Life Group, Inc.¥1824.50¥140130% above12.0x13.6%6187
POW.TO Power Corporation of CanadaC$94.45C$5765% above23.3x10.2%5864

Sector report card

Where PUK ranks against its sector peers on each metric.

Computing percentiles…
  • PR Newswire•Sep 2, 2026
    Workday Named a Leader in 2026 Gartner® Magic Quadrant™ for Cloud HCM Suites for 1,000+ Employee Enterprises for Eleventh Consecutive Year
  • PR Newswire•Apr 1, 2026
    Prudential Health Summit: Improving Care for Every Patient brings healthcare leaders together to support patients in Hong Kong and the Greater Bay Area
40 filings
October 2026
Oct 19
6-KForeign current reportPeriod 2026-10-19
View on SEC →
Oct 14
6-KForeign current reportPeriod 2026-10-14
View on SEC →
Oct 13
6-KForeign current reportPeriod 2026-10-13
View on SEC →
37 more filings + AI summaries on Investor+.INVESTOR